Clinical Trials · NCT07846865
Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea: A Randomised Comparative Effectiveness Trial
- Phase
- Phase 2/Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Woolcock Institute of Medical Research
- Enrollment
- 256
- Start date
- Oct 2026
- Locations
- 1 site, Australia
- Primary endpoint
- Breathing Disturbance Index (BDI)